JPRN-jRCT2061210008进行中（未招募）2 期
ONO-2910-02: A Phase IIa Study of ONO-2910, Randomised, Double-blind, Placebo Controlled, Parallel Group, Multi-center Trial in Patients with Diabetic Polyneuropathy
Hirashima Yoshinori0 个研究点目标入组 168 人开始时间: 2021年5月28日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 168
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 < 75age old（—）
- 性别
- All
入选标准
- •1. Type 2 diabetes with HbA1c : >= 6.5%, <= 10.0%
- •2. Patients diagnosised with diabetic polyneuropathy (DPN) by simplified diagnostic criteria for diabetic polyneuropathy proposed by the Conference on Diabetic Polyneuropathy
- •3. Patients suffering from Numbness and Tingling on both feet and their mTCNS score are >= 2 each.
排除标准
- •1. Patients who are expected to change treatment methods (drug therapy, exercise therapy, etc.) for diabetes during the study period
- •2. Patients who are expected to newly take or change the dosage and administration of peripheral neuropathic pain medication, other analgesics, or agents for overall symptoms of DPN during the study period
- •3. Patients with pain or numbness other than DPN in upper or lower limbs
研究者
相似试验
进行中（未招募）
不适用
A Randomized, Open label, Phase 2 Study of CNTO 328 (Anti IL 6 Monoclonal Antibody) and VELCADE Melphalan Prednisone Compared With VELCADE-Melphalan-Prednisone for the Treatment of Previously Untreated Multiple Myeloma - NDEUCTR2008-007157-12-ITCENTOCOR116
进行中（未招募）
1 期
A Randomized, Open label, Phase 2 Study of CNTO 328 (Anti-IL 6 Monoclonal Antibody) and VELCADE-Melphalan-Prednisone Compared With VELCADE-Melphalan-Prednisone for the Treatment of Previously Untreated Multiple MyelomaEUCTR2008-007157-12-FRCentocor BV
已完成
2 期
A Study to Compare CNTO 328 (Anti-IL-6 Monoclonal Antibody) and VELCADE-Melphalan-Prednisone (VMP) With VMP alone in Previously Untreated Multiple Myeloma PatientsCTRI/2010/091/001263Janssen Research Development LLC104
尚未招募
2 期
ONO-2808-03: A Phase 2 Study of ONO-2808 in Patients With Multiple System AtrophyMultiple System AtrophyJPRN-jRCT2041230153Sohur U.Shivraj80
进行中（未招募）
1 期
A clinical study of OPT-302 with aflibercept compared to aflibercept plus sham in patients with diabetic macular edemaEUCTR2018-003298-90-LVOpthea Ltd108